Haven't used Cellcentric limited yet?
Ask Trustburn

Ask Trustburn about Cellcentric limited

Based on 9 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Alex Berry
Reviews 1

Cellcentric limited is an average company. Their website, cellcentric.com, provides all the necessary information about the company and its products. I had an average experience with their customer service, but it could have been better. Overall, I would rate them as average.

Kenneth Zimmerle
Reviews 1

I have mixed feelings about Cellcentric limited. While their website, cellcentric.com, is well-designed and informative, their customer service needs improvement. The pricing is reasonable, but there is room for enhancement in product quality.

Arika Cason
Reviews 1

I recently came across a company with a website called cellcentric.com. They seem to have good products and services. I had a positive experience with their customer support team. The only downside is their pricing, which could be more competitive.

Cynthia Nordlund
Reviews 1

I recently availed the services of a certain company. They have a nice website, but I was not completely satisfied with their customer support. The prices, however, were reasonable. Based on my experience, I would rate them as good.

Questions & Answers

No questions yet β€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website β€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="cellcentric-limited" data-lang="en"></div>
More widgets

About Cellcentric limited

CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.

The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.

Address
Derby Rd Industrial Estate Unit 3
Categories
Biotechnology